U.S. Markets close in 5 hrs 55 mins

Understanding Nektar Therapeutics’ Top-Line Performance

Kenneth Smith
Understanding Nektar Therapeutics’ Top-Line Performance

Why Are Investors Excited about Nektar Therapeutics in 2018? Nektar Therapeutics (NKTR) generates revenues from collaboration agreements through which it receives product sales revenues, royalties, license fees, milestone payments, and contract research payments. In fiscal 2017, Nektar Therapeutics generated total revenues of $307.7 million compared with $165.4 million in fiscal 2016.